- Home
- GROV vs LTRN Comparison
GROV vs LTRN Comparison
Compare GROV & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROV
- LTRN
- Stock Information
- Founded
- GROV 2016
- LTRN 2013
- Country
- GROV United States
- LTRN United States
- Employees
- GROV N/A
- LTRN N/A
- Industry
- GROV Package Goods/Cosmetics
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- GROV Consumer Discretionary
- LTRN Health Care
- Exchange
- GROV Nasdaq
- LTRN Nasdaq
- Market Cap
- GROV 55.0M
- LTRN 49.9M
- IPO Year
- GROV N/A
- LTRN 2020
- Fundamental
- Price
- GROV $1.36
- LTRN $3.80
- Analyst Decision
- GROV Buy
- LTRN Strong Buy
- Analyst Count
- GROV 2
- LTRN 1
- Target Price
- GROV $1.60
- LTRN $25.00
- AVG Volume (30 Days)
- GROV 89.6K
- LTRN 73.1K
- Earning Date
- GROV 11-13-2025
- LTRN 11-12-2025
- Dividend Yield
- GROV N/A
- LTRN N/A
- EPS Growth
- GROV N/A
- LTRN N/A
- EPS
- GROV N/A
- LTRN N/A
- Revenue
- GROV $180,808,000.00
- LTRN N/A
- Revenue This Year
- GROV N/A
- LTRN N/A
- Revenue Next Year
- GROV $11.10
- LTRN N/A
- P/E Ratio
- GROV N/A
- LTRN N/A
- Revenue Growth
- GROV N/A
- LTRN N/A
- 52 Week Low
- GROV $1.02
- LTRN $2.55
- 52 Week High
- GROV $1.95
- LTRN $6.12
- Technical
- Relative Strength Index (RSI)
- GROV 47.14
- LTRN 55.43
- Support Level
- GROV $1.29
- LTRN $2.86
- Resistance Level
- GROV $1.40
- LTRN $3.42
- Average True Range (ATR)
- GROV 0.08
- LTRN 0.28
- MACD
- GROV 0.00
- LTRN 0.03
- Stochastic Oscillator
- GROV 43.50
- LTRN 99.80
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.